In a move towards sustainability, EnduraCure, a startup born at the University of Utah, is taking a shot at our e-waste problem by developing materials that won't just end up clogging our landfills. These novel polymer substrates, poised to be a game-changer, are designed to degrade chemically, per a recent report. As a society that's ever-dependent on gizmos and gadgets, this means consumers could soon discard their electronic devices with less environmental guilt.
It’s a significant stride considering the extent of e-waste’s impact; according to the Environmental Protection Agency, electronic waste is rapidly becoming one of the world's most alarming environmental concerns. The move by EnduraCure is timely, considering the pressure on tech companies to find eco-friendly solutions for the precious metals embedded in their circuits, often lost to the bowels of landfills, according to At The U. EnduraCure's materials are not only aimed at being easy on the environment but also at helping recover the valuable components that go into making electronic devices.
At the helm of this game-changing venture is Dennis Pruzan, impelled by his vision for resolutely circular economies, who told At The U, "It’s all about making these products degradable by design." This technology isn't just innovative; it's essential. It comes at a time when tech waste is piling up, and the flexible electronics market, which includes everything from medical sensors to smart packaging and wearable devices, is ripe for the sustainable alternative that EnduraCure is promising.
EnduraCure had its genesis in the research-loving corridors of the Wang Research Group within the Price College of Engineering, under the tutelage of assistant professor Chen Wang. Dennis Pruzan, a product of the very same institution, cut his academic teeth there before venturing out into the wilds of the industry, only to be called back when the startup needed seasoned leadership. As Pruzan explained to At The U, "One of the things I admire most about the way Chen operates his lab is that it’s with an eye on translational research." Riding the back of a Phase 1 Small Business Technology Transfer award from the NSF, EnduraCure is currently laying the groundwork to make its research commercially viable and broadly applicable.
